Effect of trazodone on cognitive decline in people with dementia: Cohort study using UK routinely collected data

Andrew Sommerlad, Nomi Werbeloff, Gayan Perera, Tanya Smith, Harry Costello, Christoph Mueller, Andrey Kormilitzin, Matthew Broadbent, Alejo Nevado‐Holgado, Simon Lovestone, Robert Stewart, Gill Livingston

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
95 Downloads (Pure)

Abstract

Objectives: Evidence in mouse models has found that the antidepressant trazodone may be protective against neurodegeneration. We therefore aimed to compare cognitive decline of people with dementia taking trazodone with those taking other antidepressants. Methods: Three identical naturalistic cohort studies using UK clinical registers. We included all people with dementia assessed during 2008–16 who were recorded taking trazodone, citalopram or mirtazapine for at least 6 weeks. Linear mixed models examined age, time and sex-adjusted Mini-mental state examination (MMSE) change in people with all-cause dementia taking trazodone compared with those taking citalopram and mirtazapine. In secondary analyses, we examined those with non-vascular dementia; mild dementia; and adjusted results for neuropsychiatric symptoms. We combined results from the three study sites using random-effects meta-analysis. Results: We included 2,199 people with dementia, including 406 taking trazodone, with mean 2.2 years follow-up. There was no difference in adjusted cognitive decline in people with all-cause or non-vascular dementia taking trazodone, citalopram or mirtazapine in any of the three study sites. When data from the three sites were combined in meta-analysis, we found greater mean MMSE decline in people with all-cause dementia taking trazodone compared to those taking citalopram (0·26 points per successive MMSE measurement, 95% CI 0·03–0·49; p = 0·03). Results in sensitivity analyses were consistent with primary analyses. Conclusions: There was no evidence of cognitive benefit from trazodone compared to other antidepressants in people with dementia in three naturalistic cohort studies. Despite preclinical evidence, trazodone should not be advocated for cognition in dementia.

Original languageEnglish
JournalInternational Journal of Geriatric Psychiatry
Volume37
Issue number1
Early online date4 Oct 2021
DOIs
Publication statusPublished - Jan 2022

Fingerprint

Dive into the research topics of 'Effect of trazodone on cognitive decline in people with dementia: Cohort study using UK routinely collected data'. Together they form a unique fingerprint.

Cite this